ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2571

Lack of Control of Hypertension in Systemic Lupus Erythematosus

Hong Fang1, Raheel Ahmad2, Laurence S. Magder3 and Michelle Petri1, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2Div of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 3Department of Epidemiology and Public Health, University of Maryland, Baltimore, MD

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Hypertension and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: ACR/REF Edmond L. Dubois, MD Memorial Lectureship: Hydroxychloroquine Reduces Thrombosis in Systemic Lupus Erythematosus, Particularly in Antiphospholipid Positive Patients

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Hypertension is an independent risk factor for both actual cardiovascular events and also subclinical atherosclerosis (coronary calcium, carotid IMT) in SLE. We examined the factors that predict poorly controlled hypertension in SLE.

Methods: There were 2,182 patients with SLE (92%  female, 56% Caucasian, and 37% African-American).  Ninety-five percent met revised American College of Rheumatology criteria for SLE. Patients were diagnosed as having hypertension if they had systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg or if receiving any anti-hypertensive medications.  Patients who had ever had hypertensive episodes during cohort follow-up were compared with patients who had never had hypertension with respect to clinical and demographic characteristics. Multivariate regression modeling using generalized estimating equations was used to assess of the association between various factors and mean systolic blood pressure over cohort follow-up among patients with hypertension.

Results:

There were a total 1630 (74%) patients with hypertension (91% female, 53% Caucasian, 42% African-American).  Compared to non-hypertensive patients, those with hypertension were more likely to be African-American (p<0.0001), male (p=0.0004), smokers (p<0.0001), alcoholic (p<0.0001), older (p<0.0001), lower education (p<0.0001), lower household income (p<0.0001), higher disease activity (p<0.0001), higher body mass index (p<0.0001), higher prednisone dose (p<0.0001),higher urine protein to creatinine ratio (p<0.0001) and higher serum creatinine (p<0.0001).

We next examined, in just the patients with hypertension, the association between clinical variables and systolic blood pressure over followup. In the table, a negative number indicates better control of hypertension.

 

Variable

Effect on Mean Systolic Blood Pressure

p-value

Age at assessment (per year)

0.22±0.03

<0.0001

Gender (female)

-4.56±1.14

<0.0001

Ethnicity

 

 

    African-American vs Caucasian

3.24±0.91

0.0004

    Other ethnicity vs Caucasian

-3.64±1.45

0.012

Years of education (per year)

-0.11±0.14

0.45

Family income (per $1,000)

0.002±0.004

0.63

Smoking

1.19±0.86

0.17

Body mass index (per kg/m2)

0.56±0.05

<0.0001

Number of anti-hypertensives

-3.08±0.35

<0.0001

Prednisone (per mg/d)

0.13±0.02

<0.0001

SELENA-SLEDAI

0.15±0.06

0.017

Urine dipstick protein

0.85±0.40

0.033

Urine protein/cr ratio

2.62±0.41

<0.0001

Serum creatinine

-1.94±0.79

0.014

In the multivariate model, age, male sex, African-American, BMI, prednisone, disease activity, and measures of renal lupus remained independent prediction of poor blood measure control.

Conclusion: Hypertension remains an independent risk factor for cardiovascular events in SLE. As in the general population, older age, male gender, and African-American ethnicity are associated with both hypertension and poor control of hypertension. In SLE, body mass index, prednisone, disease activity, and urine protein to creatinine ratio remain independent predictors of poor blood pressure control. These modifiable risk factors are potential “treat to target” goals. In SLE, use of more than one anti-hypertensive was superior in blood pressure control.


Disclosure:

H. Fang,
None;

R. Ahmad,
None;

L. S. Magder,
None;

M. Petri,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lack-of-control-of-hypertension-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology